6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Altamira Therapeutics Ltd.
Filed: February 17, 2023
Period of Report: February 17, 2023
Accession Number: 0001213900-23-012889

View Document ↗ View on SEC.gov ↗